ホシノ ジユンイチ   HOSHINO Junichi
  星野 純一
   所属   医学部 医学科(東京女子医科大学病院)
   職種   教授・基幹分野長
論文種別 原著
言語種別 英語
査読の有無 査読あり
表題 Synergistic deterioration of prognosis associated with decreased grip strength and hyporesponse to erythropoiesis-stimulating agents in patients undergoing hemodialysis.
掲載誌名 正式名:Renal failure
略  称:Ren Fail
ISSNコード:15256049/0886022X
掲載区分国外
巻・号・頁 44(1),pp.1801-1810
著者・共著者 Kobayashi Shizuka†, Tanaka Kentaro, Hoshino Junichi*, Hara Shigeko, Kushiyama Akifumi, Tanaka Yoshihide, Motonishi Shuta, Sakai Ken, Ozawa Takashi
担当区分 責任著者
発行年月 2022/12
概要 INTRODUCTION:We examined the combined effect of erythropoietin (EPO) hyporesponsiveness and low handgrip strength (HGS) on the prognosis of patients undergoing hemodialysis (HD).METHODS:We recruited patients with chronic kidney disease (CKD) Stage 5, who were undergoing HD at our dialysis clinic between January 2015 and March 2015 (n = 182). Patients of ≥20 years of age and who had been undergoing HD for ≧3 months at enrollment were eligible for inclusion. Seven patients treated with epoetin-β pegol were excluded. First, the erythropoietin resistance index (ERI) and HGS were measured. The patients were stratified by the ERI of 9.44 (U/kg/week/g/dL), and by the HGS of 28 kg for men and 18 kg for women. We then observed death and cardiovascular disease (CVD), composite endpoint (deaths or CVD) for a median of 2 years.RESULTS:A total of 175 patients (male, n = 122; female, n = 53; age, 34-92 years) were included in the analysis. During the observation period of 24 months, 57 events (14 deaths and 43 CVD) were observed. High ERI and low HGS were associated with a high incidence of endpoints compared to low ERI and high HGS. Among the four groups classified by ERI and HGS values, the highest risk group was the high ERI/low HGS group (HR: 4.20 95% CI 2.12-8.33).CONCLUSIONS:EPO hyporesponsiveness combined with low HGS were found to be significant predictors of a poor outcome, and the synergistic effects of the two factors had stronger predictive ability than either single factor.
DOI 10.1080/0886022X.2022.2106873
PMID 36305202